Swedish drug maker Recipharm looks to list or sell stake-source
STOCKHOLM (Reuters) - Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing...
Read More »STOCKHOLM (Reuters) - Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers s...
Read More »
ZURICH (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover s...
Read More »
FRANKFURT (Reuters) - Germany's largest drugmaker Bayer said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH, a ma...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a...
Read More »BEIJING (Reuters) - China has begun a crackdown on the sales of fake, diseased and tainted meat products after a series of scandals ...
Read More »
By Jonathan Kaminsky OLYMPIA, Washington (Reuters) - Key officials helping to create Washington state's potentially lucrative recrea...
Read More »By Kate Kelland LONDON (Reuters) - Bereaved parents who do not want to see their dead babies go through a conventional autopsy could...
Read More »By Toni Clarke WASHINGTON (Reuters) - Updated federal advice on mercury levels in fish appears to have stalled within the U.S. depar...
Read More »By Deena Beasley LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new ...
Read More »